A5019222729- Hepatocellular Carcinoma Treatment and Prognosis
- Esophageal and GI Pathology
- Gastrointestinal disorders and treatments
- Gastrointestinal Bleeding Diagnosis and Treatment
- Colorectal and Anal Carcinomas
- Inflammatory Bowel Disease
- Intraperitoneal and Appendiceal Malignancies
- Helicobacter pylori-related gastroenterology studies
- Gallbladder and Bile Duct Disorders
- Organ Transplantation Techniques and Outcomes
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Biliary and Gastrointestinal Fistulas
- Gastroesophageal reflux and treatments
- Colorectal Cancer Treatments and Studies
- Viral-associated cancers and disorders
- Autoimmune and Inflammatory Disorders Research
- Renal Transplantation Outcomes and Treatments
- Gastric Cancer Management and Outcomes
- IL-33, ST2, and ILC Pathways
Beijing Friendship Hospital
2022-2024
Capital Medical University
2022-2024
National Clinical Research Center for Digestive Diseases
2024
Abstract Background and Aim Duodenal ulcers, especially caused by increasingly drug‐resistant Helicobacter pylori , are a concern in Asia. We compared oral vonoprazan versus lansoprazole for efficacy (healing duodenal ulcers) safety non‐Japanese Asian patients. Methods In this phase 3, randomized (1:1), double‐blind, double‐dummy, parallel‐group, non‐inferiority study (April 5, 2017, to July 19, 2019), patients with ≥ 1 endoscopically confirmed ulcer, at 52 hospitals (China, South Korea,...
malignancy is the leading cause of death in liver transplant recipients. Numerous studies consistently show a significantly increased risk esophageal cancer after transplantation. Therefore, this study aims to investigate incidence and factors associated with